Siddharama Pawate
Siddharama Pawate
Verified email at
Cited by
Cited by
Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ
S Pawate, Q Shen, F Fan, NR Bhat
Journal of neuroscience research 77 (4), 540-551, 2004
Presentations and outcomes of neurosarcoidosis: a study of 54 cases
S Pawate, H Moses, S Sriram
QJM: An International Journal of Medicine 102 (7), 449-460, 2009
Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group
BJ Stern, W Royal, JM Gelfand, DB Clifford, J Tavee, S Pawate, JR Berger, ...
JAMA neurology 75 (12), 1546-1553, 2018
Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series
JM Gelfand, MJ Bradshaw, BJ Stern, DB Clifford, Y Wang, TA Cho, ...
Neurology 89 (20), 2092-2100, 2017
Diagnostic and therapeutic aspects of Hashimoto's encephalopathy
I Olmez, H Moses, S Sriram, H Kirshner, AH Lagrange, S Pawate
Journal of the Neurological Sciences 331 (1-2), 67-71, 2013
Extended interval dosing of natalizumab in multiple sclerosis
LZ Ryerson, TC Frohman, J Foley, I Kister, B Weinstock-Guttman, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (8), 885-889, 2016
Neurosarcoidosis: pathophysiology, diagnosis, and treatment
MJ Bradshaw, S Pawate, LL Koth, TA Cho, JM Gelfand
Neurology: neuroimmunology & neuroinflammation 8 (6), e1084, 2021
Development of chemical exchange saturation transfer at 7T
AN Dula, EM Asche, BA Landman, EB Welch, S Pawate, S Sriram, ...
Magnetic Resonance in Medicine 66 (3), 831-838, 2011
Cranial base manifestations of neurosarcoidosis: a review of 305 patients
ML Carlson, JR White Jr, M Espahbodi, DS Haynes, CLW Driscoll, ...
Otology & Neurotology 36 (1), 156-166, 2015
Extended interval dosing of natalizumab: a two-center, 7-year experience
R Bomprezzi, S Pawate
Therapeutic advances in neurological disorders 7 (5), 227-231, 2014
Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T
S By, RL Barry, AK Smith, BD Lyttle, BA Box, FR Bagnato, S Pawate, ...
Magnetic resonance in medicine 79 (2), 806-814, 2018
Untangling the R2* contrast in multiple sclerosis: a combined MRI-histology study at 7.0 Tesla
F Bagnato, S Hametner, E Boyd, V Endmayr, Y Shi, V Ikonomidou, ...
PLoS One 13 (3), e0193839, 2018
C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform
S Pawate, NR Bhat
Antioxidants & Redox Signaling 8 (5-6), 903-909, 2006
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised …
JF Foley, G Defer, LZ Ryerson, JA Cohen, DL Arnold, H Butzkueven, ...
The Lancet Neurology 21 (7), 608-619, 2022
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T
AN Dula, S Pawate, RD Dortch, RL Barry, KM George-Durrett, BD Lyttle, ...
Multiple Sclerosis Journal 22 (3), 320-328, 2016
Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation
K Kleinfeld, B Mobley, P Hedera, A Wegner, S Sriram, S Pawate
Journal of neurology 260, 558-571, 2013
Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord
BN Conrad, RL Barry, BP Rogers, S Maki, A Mishra, S Thukral, S Sriram, ...
Brain 141 (6), 1650-1664, 2018
The role of infections in the pathogenesis and course of multiple sclerosis
S Pawate, S Sriram
Annals of Indian Academy of Neurology 13 (2), 80-86, 2010
The spectrum of Susac’s syndrome
S Pawate, A Agarwal, H Moses, S Sriram
Neurological sciences 30, 59-64, 2009
Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A2 receptors
S Pawate, KL Schey, GP Meier, ME Ullian, DE Mais, PV Halushka
Journal of Biological Chemistry 273 (35), 22753-22760, 1998
The system can't perform the operation now. Try again later.
Articles 1–20